PPARG and Alzheimer disease: Interestingly, PPARγ has been shown to be elevated in AD patients (de la Monte and Wands, 2006) although our recent research using a 50 mg/kg CBD dose did not find any genotype- or treatment-related changes in this receptor (Watt et al., 2020).